EssilorLuxottica stock gains 1.4 percent while CAC 40 rises 0.9 percent

Published on 10/09/2026 at 15:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

EUR 146.18 stood on October 9, 2026, versus EUR 144.10. EssilorLuxottica stock stood 1.4 percent above its prior close while CAC 40 was up 0.9 percent.

Key points in brief

EssilorLuxottica stock was trading at EUR 146.18 at Lang & Schwarz on October 9, 2026, up 1.4 percent from EUR 144.10.
The stock remained within a EUR 138.30 to EUR 323.80 52-week range, with a P/E ratio of 27.24.
The CAC 40 was up 0.9 percent, while LVMH and Kering provided the peer comparison.
EssilorLuxottica's next third-quarter revenue release is scheduled for October 20, 2026.

Makroaufnahme einer Brillenlinse mit irisierender Antireflexschicht — EssilorLuxottica FR0000121667 zeigt Makroaufnahme einer Brillenlinse mit schillernder Antireflexbeschichtung in detailreicher blaugrüner Nahaufnahme, Illustration mit AI erstellt.

At 3:06 p.m. CEST on October 9, 2026, EssilorLuxottica (ISIN FR0000121667) was trading at EUR 146.18 at Lang & Schwarz, up 1.4 percent versus the EUR 144.10 prior close on October 8, 2026. The CAC 40 was up 0.9 percent at the same finance timestamp, giving the stock a positive but measured market comparison.

Intraday volume stays below average

EssilorLuxottica traded 261,343 shares by 2:55 p.m. CEST, compared with an average volume of 731,228 shares. That places activity at 35.7 percent of the average, so the price move came with lower turnover than the normal session benchmark.

The Lang & Schwarz bid was EUR 146.15 and the ask was EUR 146.20 at 3:06 p.m. CEST. The narrow EUR 0.05 spread placed the live quote close to the midpoint of the displayed market.

Stock remains near its yearly low

The 52-week range was EUR 138.30 to EUR 323.80 as of October 9, 2026. At EUR 146.18, EssilorLuxottica stood 5.7 percent above the low and 54.9 percent below the high, keeping the current quote near the lower end of its yearly band.

Market capitalization was EUR 67.0 billion and the price-to-earnings ratio was 27.24 as of October 9, 2026. The combination places valuation alongside a share price that remains well below its 52-week peak, although the price-to-earnings ratio is not directly comparable with the company's separate revenue trend.

Comparison with peers

EssilorLuxottica: plus 1.4 percent, P/E 27.24, market capitalization EUR 67.0 billion
LVMH (Euronext Paris, EUR): plus 0.09 percent, P/E 17.36, market capitalization EUR 188.0 billion
Kering (Euronext Paris, EUR): plus 1.23 percent, P/E minus 120.78, market capitalization EUR 25.6 billion

October 20 revenue date

Boursorama lists EssilorLuxottica's third-quarter revenue release for October 20, 2026. The date gives the next scheduled operating checkpoint after the current market snapshot.

On September 22, 2026, EssilorLuxottica reported six-month interim treatment effects of 0.51 D for myopia progression and 0.21 mm for axial elongation in an ongoing China trial, according to EssilorLuxottica. The announcement adds an operating reference point, while the market report remains centered on the live share price.

Live quote and investor context

EssilorLuxottica was trading at EUR 146.18 at Lang & Schwarz on October 9, 2026 at 3:06 p.m. CEST, up 1.4 percent versus the EUR 144.10 prior close at Lang & Schwarz on October 8, 2026. The further course of trading is shown by the continuously updated real-time quote of EssilorLuxottica stock.